FR3889M - - Google Patents

Info

Publication number
FR3889M
FR3889M FR997779A FR997779A FR3889M FR 3889 M FR3889 M FR 3889M FR 997779 A FR997779 A FR 997779A FR 997779 A FR997779 A FR 997779A FR 3889 M FR3889 M FR 3889M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR997779A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR3889M publication Critical patent/FR3889M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
FR997779A 1963-12-13 1964-12-08 Expired FR3889M (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB49408/63A GB1110947A (en) 1963-12-13 1963-12-13 Guanidines

Publications (1)

Publication Number Publication Date
FR3889M true FR3889M (is) 1966-01-31

Family

ID=10452240

Family Applications (1)

Application Number Title Priority Date Filing Date
FR997779A Expired FR3889M (is) 1963-12-13 1964-12-08

Country Status (8)

Country Link
US (1) US3409669A (is)
BE (1) BE656923A (is)
CH (1) CH471071A (is)
DE (1) DE1214674B (is)
FR (1) FR3889M (is)
GB (1) GB1110947A (is)
NL (1) NL6413937A (is)
SE (1) SE331090B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
DE69133065T2 (de) 1990-03-02 2003-02-27 Oregon State Tri- und tetra-substituierte guanidine und deren verwendung als antagonisten von exzitatorischen aminosäuren
AU653729B2 (en) * 1990-05-25 1994-10-13 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Substituted guanidines having high binding to the sigma receptor and the use thereof
DE69233479T2 (de) * 1991-02-08 2006-03-16 Scion Pharmaceuticals, Inc., Medford Substituierte Guanidine und Derivate hiervon als Modulatoren der Freisetzung von Neurotransmittern und neue Methode zur Identifizierung von Inhibitoren der Neurotransmitter-Freisetzung
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
CA2163361C (en) * 1993-05-27 2008-06-17 Graham J. Durant Therapeutic substituted guanidines
CA2177081A1 (en) * 1993-11-23 1995-06-01 Graham J. Durant Therapeutic substituted guanidines
EP0751767A4 (en) 1994-02-03 1997-12-10 Cambridge Neuroscience Inc GUANIDINE FOR THERAPEUTIC USE
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3291829A (en) * 1961-03-02 1966-12-13 Ciba Geigy Corp Alkyl guanidines

Also Published As

Publication number Publication date
US3409669A (en) 1968-11-05
DE1214674B (de) 1966-04-21
GB1110947A (en) 1968-04-24
CH471071A (de) 1969-04-15
SE331090B (is) 1970-12-14
BE656923A (is) 1965-06-10
NL6413937A (is) 1965-06-14

Similar Documents

Publication Publication Date Title
FR3889M (is)
BE627012A (is)
BE627025A (is)
BE623117A (is)
BE644020A (is)
BE643698A (is)
BE643536A (is)
BE642516A (is)
BE642308A (is)
BE642270A (is)
BE641322A (is)
BE640797A (is)
BE639529A (is)
BE636952A (is)
BE627023A (is)
BE627172A (is)
BE621232A (is)
BE627145A (is)
BE627141A (is)
BE627083A (is)
BE644940A (is)
BE621517A (is)
BE630468A (is)
BE644662A (is)
BE625880A (is)